Insurance Stocks Moving In Monday’s Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today’s Intraday session. Gainers…

According to Benzinga Pro following are the gainers and losers in Insurance industry for today’s Intraday session.

Gainers

  • Citizens (NYSE:CIA) shares moved upwards by 4.5% to $2.21 during Monday’s regular session. The current volume of 65.7K shares is 62.7% of Citizens’s average full-day volume over the last 100 days (last updated at 13:40 EST). The market value of their outstanding shares is at $108.6 million.
  • SelectQuote (NYSE:SLQT) shares moved upwards by 3.74% to $1.94. SelectQuote’s stock is trading at a volume of 952.6K shares as of 13:40 EST. This is 55.9% of its average full-day volume over the last 100 days. The company’s market cap stands at $324.9 million.
  • eHealth (NASDAQ:EHTH) stock rose 3.44% to $8.72. eHealth’s stock is trading at a volume of 255.9K shares as of 13:40 EST. This is 46.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $243.8 million.
  • Kingsway Financial Servs (NYSE:KFS) shares moved upwards by 2.48% to $9.08. Kingsway Financial Servs’s stock is trading at a volume of 139.1K shares as of 13:40 EST. This is 187.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $238.2 million.
  • F&G Annuities & Life (NYSE:FG) stock increased by 2.11% to $22.0. Trading volume for F&G Annuities & Life’s stock is 115.4K as of 13:40 EST. This is 65.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.7 billion.
  • Bright Health Gr (NYSE:BHG) shares rose 1.5% to $10.77. Bright Health Gr’s stock is trading at a volume of 90.8K shares as of 13:40 EST. This is 44.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $84.8 million.

Losers

  • Huize Holding (NASDAQ:HUIZ) shares declined by 5.23% to $1.27 during Monday’s regular session. Trading volume for Huize Holding’s stock is 45.2K as of 13:40 EST. This is 17.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $64.9 million. As per the news, the Q1 earnings report came out 4 days ago.
  • Waterdrop (NYSE:WDH) stock decreased by 4.71% to $2.23. Trading volume for this security as of 13:40 EST is 455.4K, which is 75.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $847.3 million. As per the news, the Q1 earnings report came out yesterday.
  • SiriusPoint (NYSE:SPNT) stock decreased by 4.46% to $9.01. The current volume of 219.2K shares is 33.9% of SiriusPoint’s average full-day volume over the last 100 days (last updated at 13:40 EST). The company’s market cap stands at $1.4 billion.
  • Hallmark Financial Servs (NASDAQ:HALL) stock declined by 3.89% to $4.2. The current volume of 5.9K shares is 41.8% of Hallmark Financial Servs’s average full-day volume over the last 100 days (last updated at 13:40 EST). The company’s market cap stands at $7.6 million.
  • Fanhua (NASDAQ:FANH) stock declined by 3.68% to $7.99. As of 13:40 EST, this security is trading at a volume of 38.6K shares, making up 92.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $464.7 million. As per the news, the Q1 earnings report came out 4 days ago.
  • Oxbridge Re Holdings (NASDAQ:OXBR) shares fell 3.32% to $1.46. Oxbridge Re Holdings’s stock is trading at a volume of 11.5K shares as of 13:40 EST. This is 74.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.5 million.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Blindness-Focused LENZ Therapeutics’ Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says

Advances in presbyopia treatment with LENZ Therapeutics' LNZ100. Clinically proven to enhance near-vision for up to 10 hours, it offers a promising alternative to reading glasses. Analysts predict a bright future with a Buy rating and $34 price target.

ABBV